Vimarsana
Biggest News Aggregation in the World

Page 11 - Lymph Node News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lymph Node. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lymph Node Today - Breaking & Trending Today

When the body's B cell training grounds stay open after hours - Vimarsana News

When the body's B cell training grounds stay open after hours

A lymph node with clusters of germinal centers full of mature B cells (red), dotted with less evolved “naive” B cells (green). 

Study reveals why human lymph nodes lose their function with age - Vimarsana News

Study reveals why human lymph nodes lose their function with age

A new study from researchers at Uppsala University presents novel findings on why human lymph nodes lose their function with age and the consequences for the effectiveness of our immune system. The article has been published in The Journal of Pathology.

Teddi Mellencamp's melanoma surgeries 'successful' - Vimarsana News

Teddi Mellencamp's melanoma surgeries 'successful'

Teddi Mellencamp has been left feeling "very blessed" as her melanoma surgeries were "successful", after she went under the knife to have 11 melanomas and three lymph nodes removed.

New ASTRO guideline provides recommendations on the use of radiation therapy for endometrial cancer - Vimarsana News

New ASTRO guideline provides recommendations on the use of radiation therapy for endometrial cancer

A newly updated clinical guideline from the American Society for Radiation Oncology provides recommendations on the use of radiation therapy and systemic therapy after surgery to treat patients with endometrial cancer.

Genomic assay can help identify breast cancer patients who may benefit from ovarian suppression therapy - Vimarsana News

Genomic assay can help identify breast cancer patients who may benefit from ovarian suppression therapy

Among premenopausal women with hormone receptor (HR)-positive, early-stage breast cancer enrolled in the SOFT trial, those with a high score on a genomic assay called Breast Cancer Index (BCI) had increased risk of distant recurrence, and those with low BCI benefited more from the addition of ovarian suppression therapy to endocrine therapy after 12 years of follow-up, according to data presented at the San Antonio Breast Cancer Symposium, held December 6-10, 2022.